Eden s Answers Inc. and Sprigs Life Inc. 12/14/17
|
|
- Sophia Stevens
- 5 years ago
- Views:
Transcription
1 Eden s Answers Inc. and Sprigs Life Inc. 12/14/17 Cincinnati District Office 6751 Steger Drive Cincinnati, OH Telephone: (513) FAX: (513) December 14, 2017 VIA UPS Overnight Delivery Jonathan Laudon, Owner Nancy Laudon, Owner Eden s Answers Inc. and Sprigs Life Inc S. Florida Avenue Lakeland, FL Dear Mr. Laudon and Ms. Laudon: WARNING LETTER From August 1 through August 17, 2017 the U.S. Food and Drug Administration (FDA) conducted an inspection of your facilities (Eden s Answers Inc. and Sprigs Life Inc.) located at 13754A Lawnfield Street SW, Beach City, Ohio. Based on the inspection, a review of the product labels collected during the inspection, and a review of your website at we have identified serious violations of the Federal Food, Drug, and Cosmetic Act (the Act) and applicable regulations. You may find the Act and FDA regulations through links on FDA s website at ( Unapproved New Drugs/Misbranded Drugs FDA reviewed your website at the Internet address in October 2017 and has determined that you take orders there for the products Pedia Para-Free, Lil Ones Breathe Easy, Respiratory Aid, Raw Elderberry and Honey, and Women s Hormonal Help Life Stage 2. The claims on your website establish that these products are drugs under section 201(g)(1)(B) of the Act [21 U.S.C. 321(g)(1)(B)] because they are intended for use in the cure, mitigation, treatment, or
2 prevention of disease. As explained further below, introducing or delivering these products for introduction into interstate commerce for such uses violates the Act. Examples of some of the website claims that provide evidence that your products are intended for use as drugs include: Pedia Para-Free Parents favorite for: Pinworms, Tapeworm, Hookworm, Roundworm, Flatworm blood fluke, Giardia, Toxoplasma Lil Ones Breathe Easy Fights congestion Parents favorite for: Seasonal Allergies, Colds, Flu, Congestion, Runny Nose, Sinus Infections When allergies and colds are sweeping through your house, Lil Ones Breathe Easy can help Respiratory Aid Fights congestion, naturally Customers favorite for: Cough, Cold, Flu, Bronchitis, Emphysema Respiratory Aid gives your body the support it needs for handling congestion Raw Elderberry and Honey Customers favorite for: Cold, Flu, Infection, Inflammation, Mucus, Sinus Infection, Hay Fever Women s Hormonal Help Life Stage 2 Customers favorite for: Depression Postpartum, Endometriosis Your products are not generally recognized as safe and effective for the above-referenced uses and therefore, the products are new drugs under section 201(p)(1) of the Act [21 U.S.C. 321(p) (1)]. New drugs may not be legally introduced or delivered for introduction into interstate commerce without prior approval from FDA, as described in sections 301(d) and 505(a) of the Act [21 U.S.C. 331(d) and 355(a)]. FDA approves a new drug on the basis of scientific data and information demonstrating that the drug is safe and effective. A drug is misbranded under section 502(f)(1) of the Act [(21 U.S.C. 352(f)(1)]) if the drug fails to bear adequate directions for its intended use(s). Adequate directions for use means directions under which a layperson can use a drug safely and for the purposes for which it is intended (21 CFR 201.5). Prescription drugs, as defined in section 503(b)(1)(A) of the Act [21 U.S.C. 353(b) (1)(A)], can only be used safely at the direction, and under the supervision, of a licensed practitioner. Your Respiratory Aid and Women s Hormonal Help Life Stage 2 products are intended for treatment of one or more diseases that are not amenable to self-diagnosis or treatment without the supervision of a licensed practitioner. Therefore, it is impossible to write adequate directions for a layperson to use these products safely for their intended purposes. Accordingly, Respiratory Aid and Women s Hormonal Help Life Stage 2 fail to bear adequate directions for their intended use and, therefore, the products are misbranded under section 502(f)(1) of the Act [21 U.S.C. 352(f)
3 (1)]. The introduction or delivery for introduction into interstate commerce of these misbranded drugs violates section 301(a) of the Act [21 U.S.C. 331(a)]. Misbranded Dietary Supplements Further, even if your Pedia Para-Free, Lil Ones Breathe Easy, Respiratory Aid, and Raw Elderberry and Honey products were not unapproved new drugs, these products would still be misbranded within the meaning of section 403 [21 U.S.C. 343] of the Act, and the regulations implementing the food labeling requirements of the Act, which are found in 21 CFR Part 101. Specifically during the inspection of your facility, our investigator collected labels associated with many of your products, including those listed above and your Lil Ones Calm and Focus. Our review of your product labels revealed that your products are misbranded within the meaning of section 403 of the Act [21 U.S.C. 343], as follows: 1. Your Respiratory Aid, Pedia Para-Free, Raw Elderberry and Honey, Lil Ones Calm and Focus, and Lil Ones Breathe Easy products are misbranded within the meaning of section 403(q) (1)(A) of the Act [21 U.S.C. 343(q)(1)(A)] in that the serving size declared on the labels are incorrect. Serving size for a dietary supplement is the maximum amount consumed per eating occasion as recommended on the product label as defined in 21 CFR 101.9(b) and 21 CFR (b) Table 2. For example, Your Respiratory Aid product label suggests consumers take 2 droppers hourly but the nutrition information is based on 1 drop. The serving size should be listed as 2 droppers. Your Pedia Para-Free product label suggests children 40 pounds or more take one dropper three times a day, but the serving size is listed as 1 drop. Your Raw Elderberry and Honey product label indicates a range for the serving size rather than the maximum amount per eating occasion. Furthermore, the label s serving size must include the equivalent metric quantity in parentheses following the common household measure. Your Lil Ones Calm and Focus product label suggests ages 10 years and up take 30 drops 3 times daily, but the serving size is ½ tsp. The serving size should be listed as 30 drops. Your Lil Ones Breathe Easy product label suggests adults take drops 3 times daily, but the serving size is 2/3 tsp. The serving size should be listed as 40 drops. 2. Your Respiratory Aid, Pedia Para-Free, and Lil Ones Breathe Easy products are misbranded within the meaning of section 403(q)(5)(F) of the Act [21 U.S.C. 343 (q)(5)(f)] in that the presentation of the nutrition information on the labeling does not comply with 21 CFR For example, dietary ingredients for which RDIs or DRVs have not been established are not listed within the Supplement Facts panel in accordance with 21 CFR (b)(3). 3. Your Respiratory Aid, Raw Elderberry and Honey, Lil Ones Breathe Easy, and Pedia Para- Free products are misbranded within the meaning of section 403(s)(2)(A)(ii)(I) and 403(q)(5)(F) of the Act [21 U.S.C. 343 (s)(2)(a)(ii)(i) and 403(q)(5)(F)] in that the labels fail to include the quantitative amount per serving size of all the dietary ingredients, as required by 21 CFR Your Raw Elderberry and Honey product is misbranded within the meaning of section 403(q) (1)(B) of the Act [21 U.S.C. 343 (q)(1)(b)] because the label fails to declare the correct number of servings per container in accordance with 21 CFR (b)(1)(ii). Specifically, the number of servings is stated as a range instead of one value.
4 5. Your Respiratory Aid, Raw Elderberry and Honey, Menstrual Ease, Pedia Para-Free, Lil Ones Calm and Focus, and Lil Ones Breathe Easy products are misbranded within the meaning of section 403(s)(2)(C) of the Act [21 U.S.C. 343(s)(2)(C)], in that the labels fail to identify the part of the plant (e.g., root, leaves) from which each botanical dietary ingredient in the product is derived, as required by 21 CFR 101.4(h)(1). The violations cited in this letter are not intended to be an all-inclusive list of violations that exist at your facility or in connection with your products. You are responsible for investigating and determining the causes of the violations identified above and for preventing their recurrence or the occurrence of other violations. It is your responsibility to ensure that your firm complies with all requirements of the Act and all implementing regulations. You should take prompt action to correct the violations cited in this letter. Failure to promptly correct these violations may result in enforcement action such as seizure and/or injunction without further notice. We also offer the following comments: Your Testo Strong XY product labeling information that appears on your website lists the ingredient Siberian Ginseng. The term "ginseng" may only be considered to be a common or usual name (or part thereof) for any herb or herbal ingredient derived from a plant classified within the genus Panax. Specifically, your product contains an ingredient identified as Siberian Ginseng which is Eleutherococcus senticosus. That ingredient may not be declared under a name that includes the term "ginseng" because it is not from the genus Panax. Furthermore, the Testo Strong XY labeling on your website fails to identify the part of the plant (e.g., root, leaves) from which each botanical dietary ingredient in the product is derived, as required by 21 CFR 101.4(h)(1). Your Respiratory Aid, Raw Elderberry and Honey, and Pedia Para-Free product labels must present the name and place of business on the principal display panel or the information panel in accordance with 21 CFR 101.2(b). Further, we note that your Respiratory Aid and Raw Elderberry and Honey products list Evergreen Distributing, the former name of Sprigs Life, as the business name. Your Raw Elderberry and Honey product includes raw clover honey as an ingredient. If dietary ingredients such as sugar, total carbohydrate, or calories are present in significant amounts per serving, they must be declared in the Supplement Facts (see 21 CFR (b)(2)). Your Menstrual Ease product label suggests consumers take (1/2-1 tsp) in 4 oz. of water. There is no unit stated for You should respond in writing within fifteen (15) working days from your receipt of this letter. Your response should outline the specific steps you have taken to correct these violations, including an explanation of each step taken to prevent these violations and copies of supporting documentation such as evidence of your revised and corrected web pages. If you cannot complete corrective actions within fifteen (15) business days, state the reason for the delay and the date by which these activities will be completed. Your reply should be addressed to the U.S. Food and Drug Administration; Attn: Stephen J. Rabe, Compliance Officer; 6751 Steger Drive, Cincinnati, OH or via at Stephen.rabe@fda.hhs.gov (mailto:stephen.rabe@fda.hhs.gov). You may reach Mr. Rabe at , extension 2163 if you have any questions about this matter.
5 Sincerely, /S/ Acting, Director, Division V Office of Human and Animal Foods Operations - East Cc: Leroy J. Miller, Production Manager Eden s Answers Inc./Sprigs Life, Inc A Lawnfield Street SW Beach City, Ohio More in 2017 (/ICECI/EnforcementActions/WarningLetters/2017/default.htm)
Rock Solid Nutrition, LLC 12/22/16
Rock Solid Nutrition, LLC 12/22/16 December 22, 2016 WARNING LETTER Kansas City District Office 8050 Marshall Drive - Suite 205 Lenexa, Kansas 66214-1524 913-495-5100 VIA UNITED PARCEL SERVICE OVERNIGHT
More informationOpiate Freedom Center 1/11/18
Opiate Freedom Center 1/11/18 UNITED STATES OF AMERICA DEPARTMENT OF HEALTH FEDERAL TRADE COMMISSION AND HUMAN SERVICES BUREAU OF CONSUMER FOOD AND DRUG ADMINISTRATION PROTECTION SILVER SPRING, MD 20993
More informationReishi D. International, Inc. 2/6/18
Reishi D. International, Inc. 2/6/18 San Francisco District Office 1431 Harbor Bay Parkway Alameda, CA 94502-7070 Via UPS Overnight February 7, 2018 Mr. Zheng Xiong Li, CEO Reishi D. International, Inc.
More informationLong Life Unlimited 1/31/18
Long Life Unlimited 1/31/18 Cincinnati District Office 6751 Steger Drive Cincinnati, OH 45237 Telephone: (513) 679-2700 FAX: (513) 679-2772 WARNING LETTER 533282 January 31, 2018 VIA UPS Long Life Unlimited,
More informationBetter Health Lab, Inc 2/18/15
U.S. Food and Drug Administration Protecting and Promoting Your Health Better Health Lab, Inc 2/18/15 Department of Health and Human Services Public Health Service Food and Drug Administration New Jersey
More informationTSDR Pharmacy Inc. dba brandmd Skin Care 11/9/17
TSDR Pharmacy Inc. dba brandmd Skin Care 11/9/17 Division of Pharmaceutical Quality Operations IV 19701 Fairchild, Irvine, CA 92612-2506 Telephone: 949-608-2900 Fax: 949-608-4417 WARNING LETTER VIA SIGNATURE
More informationAie Pharmaceuticals Inc 4/17/17
Aie Pharmaceuticals Inc 4/17/17 WARNING LETTER Los Angeles District 19701 Fairchild Road Los Angeles, CA 92612 UNITED PARCEL SERVICE SIGNATURE REQUIRED April 17, 2017 Dr. Magdi Youssef AIE Pharmaceuticals,
More informationTruVision Health LLC 11/30/17
TruVision Health LLC 11/30/17 Denver District Office 6 th Ave & Kipling St, Bldg 20 DFC P.O. Box 25087 Denver, CO 80225 November 30, 2017 WARNING LETTER Via UPS Overnight Ref: # HAFW4(DEN)-18-02-WL David
More informationLopez Gonzalez Santana Corporation dba Domel and dba Dermixx 8/28/17
Lopez Gonzalez Santana Corporation dba Domel and dba Dermixx 8/28/17 Office of Human and Animal Food Operations East Division IV Compliance Branch 466 Avenida Fernández Juncos San Juan, Puerto Rico 00901-3223
More informationSanapac Co., Inc. 3/24/17
Sanapac Co., Inc. 3/24/17 WARNING LETTER 17 PHI 07 PHILADELPHIA DISTRICT U.S. CUSTOMHOUSE 2ND AND CHESTNUT STREETS ROOM 900 PHILADELPHIA, PA 19106 TELEPHONE: 215 597 4390 VIA UNITED PARCEL SERVICE OVERNIGHT
More informationSan Diego Compounding Pharmacy 9/25/17
San Diego Compounding Pharmacy 9/25/17 Division of Pharmaceutical Quality Operations IV 19701 Fairchild Road Los Angeles, CA 92612 WARNING LETTER VIA UNITED PARCEL SERVICE SIGNATURE REQUIRED September
More informationOptimum Bioenergy International Corp. 12/21/17
Optimum Bioenergy International Corp. 12/21/17 Office of Human and Animal Food Division 5 West 1431 Harbor Bay Parkway Alameda, CA 94502-7070 Sent Via UPS Signature Required WARNING LETTER December 21,
More informationPick and Pay Inc dba Cili Minerals 5/8/15
U.S. Food and Drug Administration Protecting and Promoting Your Health Pick and Pay Inc dba Cili Minerals 5/8/15 Department of Health and Human Services Public Health Service Food and Drug Administration
More informationHieber's Pharmacy 12/5/17
Hieber's Pharmacy 12/5/17 Division of Pharmaceutical Quality Operations I 10 Waterview Blvd, 3rd FL Parsippany, NJ 07054 Telephone: (973) 331-4900 FAX: (973) 331-4969 CERTIFIED MAIL RETURN RECEIPT REQUESTED
More informationGenetic Edge Compounds LLC 4/14/17
Genetic Edge Compounds LLC 4/14/17 April 14, 2017 2017 DAL WL 15 UPS Overnight Bradley N. Howard, Owner and CEO Genetic Edge Compounds, LLC (b)(6), (b)(7)(c) McKinney, Texas 75070 Mr. Howard: WARNING LETTER
More informationTown and Country Compounding and Consultation Services, LLC 10/17/17
Town and Country Compounding and Consultation Services, LLC 10/17/17 Division of Pharmaceutical Quality Operations I 10 Waterview Blvd, 3rd FL Parsippany, NJ 07054 Telephone: (973) 331-4900 FAX: (973)
More informationTobin's Royal Stag, Inc. dba Tobin Farms Velvet Antler 4/19/17
Tobin's Royal Stag, Inc. dba Tobin Farms Velvet Antler 4/19/17 UNITED PARCEL SERVICE OVERNIGHT DELIVERY April 19, 2017 Darrell Tobin Owner Tobin's Royal Stag, Inc. P.O. Box 108 Alna, ME 04535 0108 Dear
More informationStonegate Pharmacy LP 11/10/16
Stonegate Pharmacy LP 11/10/16 November 10, 2016 2017 DAL WL 03 WARNING LETTER UPS Overnight Rene F. Garza, Pharm.D., Chief Executive Officer Stonegate Pharmacy, LP 2501 W. William Cannon Drive, Suite
More informationTalon Compounding Pharmacy 10/3/17
Talon Compounding Pharmacy 10/3/17 Office of Pharmaceutical Quality Operations, Division II 4040 N. Central Expressway, Suite 300 Dallas, Texas 75204 October 3, 2017 CMS Case # 522630 VIA UPS EXPRESS WARNING
More informationInspections, Compliance, Enforcement, and Criminal Investigations
Page 1 of 5 Home Inspections, Compliance, Enforcement, and Criminal Investigations Enforcement Actions Warning Letters Inspections, Compliance, Enforcement, and Criminal Investigations V-SAB Medical Labs,
More informationTheoriginalhcgdrops.com 11/28/11
Theoriginalhcgdrops.com 11/28/11 UNITED STATES OF AMERICA FEDERAL TRADE COMMISSION BUREAU OF CONSUMER PROTECTION WASHINGTON, D.C. 20580 DEPARTMENT OF HEALTH AND HUMAN SERVICES FOOD AND DRUG ADMINISTRATION
More informationAbsonutrix 7/25/17. Atlanta District Office 60 8th Street NE Atlanta, GA July 25, 2017 VIA UPS
Absonutrix 7/25/17 Atlanta District Office 60 8th Street NE Atlanta, GA 30309 July 25, 2017 VIA UPS Himanshu Nautiyal, Owner Absonutrix, LLC 317 S. Westgate Drive Suite J Greensboro, NC 27407 WARNING LETTER
More informationMay 12, 2017 WARNING LETTER
U.S. Food and Drug Administration Seattle District Office 22215 26th Avenue SE, Suite 210 Bothell, Washington 98021 May 12, 2017 OVERNIGHT DELIVERY SIGNATURE REQUIRED In reply refer to WL SEA 17-14 Otto
More informationNestle Infant Nutrition 10/31/14
U.S. Food and Drug Administration Protecting and Promoting Your Health Nestle Infant Nutrition 10/31/14 OCT 31, 2014 Department of Health and Human Services Public Health Service Food and Drug Administration
More informationNew England Compounding Center 04-Dec-06
New England Compounding Center 04-Dec-06 Department of Health and Human Services Public Health Service Food and Drug Administration New England District One Montvale Avenue Stoneham, Massachusetts 02180
More informationPublic Health Service Food and Drug Administration Dallas District 4040 North Central Expressway Dallas, Texas
Department of Health and Human Services Public Health Service Food and Drug Administration Dallas District 4040 North Central Expressway Dallas, Texas 75204-3128 March 30, 2010 2010-DAL-WL-08 CERTIFIED
More informationRed Mill Farms LLC 9/17/15
U.S. Food and Drug Administration Protecting and Promoting Your Health Red Mill Farms LLC 9/17/15 Department of Health and Human Services Public Health Service Food and Drug Administration PHILADELPHIA
More informationPublic Health Service Food and Drug Administration San Francisco District 1431 Harbor Bay Parkway Alameda, CA Telephone: 510/
Department of Health and Human Services Public Health Service Food and Drug Administration San Francisco District 1431 Harbor Bay Parkway Alameda, CA 94502-7070 Telephone: 510/337-6700 WARNING LETTER December
More informationInspections, Compliance, Enforcement, and Criminal Investigations
Page 1 of 6 Home Inspections, Compliance, Enforcement, and Criminal Investigations Enforcement Actions Warning Letters Inspections, Compliance, Enforcement, and Criminal Investigations P.A. Benjamin Manufacturing
More informationRaritan Pharmaceuticals, Inc. 6/20/17
Raritan Pharmaceuticals, Inc. 6/20/17 U.S. Food & Drug Administration Division of Pharmaceutical Quality Operations I New Jersey District 10 Waterview Boulevard, 3rd Floor Parsippany, NJ 07054 June 20,
More informationCase: 5:15-cr DCR-REW Doc #: 1 Filed: 10/01/15 Page: 1 of 15 - Page ID#: 1
Case: 5:15-cr-00087-DCR-REW Doc #: 1 Filed: 10/01/15 Page: 1 of 15 - Page ID#: 1 UNITED STATES OF AMERICA UNITED STATES DISTRICT COURT EASTERN DISTRICT OF KENTUCKY CENTRAL DIVISION LEXINGTON EastemDistr1ot
More informationDEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Apini$r$iy -tq 5-f
DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Apini$r$iy -tq 5-f J Dallas District 4040 North Central Expressway Dallas, Texas 75204-3145 Ref: 2004-DAL-WL-03 WARNING LETTER CERTIFIED MAIL RETURN
More informationNYSW Beverage Brands 1/7/15
8/26/2015 2015 > NYSW Beverage Brands 1/7/15 U.S. Food and Drug Administration Protecting and Promoting Your Health NYSW Beverage Brands 1/7/15 SHARE (HTTPS://WWW.FACEBOOK.COM/SHARER/SHARER.PHP? U=HTTP%3A%2F%2FWWW.FDA.GOV%2FICECI%2FENFORCEMENTACTIONS%2FWARNINGLETTERS%2F2015%2FUCM429530.HTM)
More informationcgmp (21 CFR 111) Regulation and Compliance Overview
cgmp (21 CFR 111) Regulation and Compliance Overview Neogen Effective Compliance Seminar September 23, 2014 Michael McGuffin President, American Herbal Products Association mmcguffin@ahpa.org Regulation
More informationCERTIFIED MAIL RETURN RECEIPT REQUESTED. Esther Hernandez President United States Blood Bank, Inc NW 95th Avenue Miami, Florida
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Silver Spring MD 20993 CERTIFIED MAIL RETURN RECEIPT REQUESTED Esther Hernandez President United States Blood Bank, Inc. 2400 NW 95th
More informationInspections, Compliance, Enforcement, and Criminal Investigations
Page 1 of 6 Home Inspections, Compliance, Enforcement, and Criminal Investigations Enforcement Actions Warning Letters Inspections, Compliance, Enforcement, and Criminal Investigations A Nelson & Co.,
More informationInspections, Compliance, Enforcement, and Criminal Investigations
Page 1 of 9 Inspections, Compliance, Enforcement, and Criminal Investigations Phoenix Medical Devices, LLC 9/29/2009 Department of Health and Human Services Public Health Service Food and Drug Administration
More informationGuidance for Industry
Guidance for Industry Dosage Delivery Devices for OTC Liquid Drug Products DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding this
More informationNOTICE OF INITIATION OF DISQUALIFICATION PROCEEDINGS AND OPPORTUNITY TO EXPLAIN
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 1401 Rockville Pike Rockville, MD 20852-1448 September 26, 2011 By Overnight Delivery Michael Dean Berger, M.D.
More informationIN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW MEXICO ) ) ) ) ) ) ) ) ) INFORMATION. General Allegations. A. Introduction and Background
IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW MEXICO UNITED STATES OF AMERICA, Plaintiff, vs. MOHAMED BASEL ASWAD, M.D., Defendant. CRIMINAL NO. 21 U.S.C. 331(a and 333(a(1: Introduction
More informationSandoz Inc. 12-Aug-08
Sandoz Inc. 12-Aug-08 Department of Health and Human Services Public Health Service Food and Drug Administration Atlanta District Office 60 8th Street, N.E. Atlanta, Georgia 30309 August 12, 2008 VIA FEDERAL
More informationResponsibilities of Laser Light Show Projector Manufacturers, Dealers, and Distributors; Final Guidance for Industry and FDA.
Responsibilities of Laser Light Show Projector Manufacturers, Dealers, and Distributors; Final Guidance for Industry and FDA (Laser Notice 51) Document issued on: May 27, 2001 U.S. Department of Health
More informationRE: Permits under the Arizona Pharmacy Act should not be required for dietary supplements
Board Members Arizona State Board of Pharmacy 1616 W. Adams St., Suite 120 Phoenix, AZ 85007 c/o Kam Gandhi, PharmD Executive Director Arizona State Board of Pharmacy Via email: kgandhi@azpharmacy.gov
More informationSUPPLEMENTS PACKAGING 101: ELEMENTS, PLACEMENT, LABELING AND CLAIMS. an ebook from ESHA Research
SUPPLEMENTS PACKAGING 101: ELEMENTS, PLACEMENT, LABELING AND CLAIMS an ebook from ESHA Research SUPPLEMENTS PACKAGING 101 2 TABLE OF CONTENTS Introduction... 3 Definition... 4 Packaging Basics... 5 What
More informationApril 30, By Electronic Mail
April 30, 2018 By Electronic Mail Dr. Scott Gottlieb, Commissioner Office of the Commissioner Food and Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20993 CommissionerFDA@fda.hhs.gov
More informationTeva Pharmaceuticals USA Attention: Scott D. Tomsky Vice President, US Generics Regulatory Affairs 425 Privet Road Horsham, PA 19044
DEPARTMENT OF HEALTH & HUMAN SERVICES ANDA 090783 Food and Drug Administration Silver Spring, MD 20993 Teva Pharmaceuticals USA Attention: Scott D. Tomsky Vice President, US Generics Regulatory Affairs
More information2014 FDA/JIFSAN Food & Nutrition Webinar
2014 FDA/JIFSAN Food & Nutrition Webinar Medical Foods Shawne Suggs-Anderson, MMSc, _ RD Infant Formula and Medical Foods Staff ONLDS/CFSAN/FDA September 23, 2014 53 Main Objectives History What is a Medical
More informationDetermining Whether A Dietary Supplement Study Requires an Investigational New Drug (IND)
Determining Whether A Dietary Supplement Study Requires an Investigational New Drug (IND) 02/02/16 description Does a study that claims their dietary supplement promotes healthy joints and cartilage or
More informationNOTICE OF INITIATION OF DISQUALIFICATION PROCEEDINGS AND OPPORTUNITY TO EXPLAIN (NIDPOE)
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration Silver Spring, MD 20993 NOTICE OF INITIATION OF DISQUALIFICATION PROCEEDINGS AND OPPORTUNITY TO EXPLAIN (NIDPOE)
More informationOver-the-Counter Pediatric Liquid Drug Products Containing Acetaminophen
Reprinted from FDA s website by EAS Consulting Group, LLC Over-the-Counter Pediatric Liquid Drug Products Containing Acetaminophen Guidance for Industry DRAFT GUIDANCE This guidance document is being distributed
More informationNOTICE OF INITIATION OF DISQUALIFICATION PROCEEDINGS AND OPPORTUNITY TO EXPLAIN (NIDPOE)
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration Silver Spring, MD 20993 NOTICE OF INITIATION OF DISQUALIFICATION PROCEEDINGS AND OPPORTUNITY TO EXPLAIN (NIDPOE)
More informationClass II Special Controls Guidance Document: Intraoral Devices for Snoring and/or Obstructive Sleep Apnea; Guidance for Industry and FDA
Class II Special Controls Guidance Document: Intraoral Devices for Snoring and/or Obstructive Sleep Apnea; Guidance for Industry and FDA Document issued on: November 12, 2002 This document supersedes the
More information,,~ 30! Premarket Notification - SomnoMed MAS Flex "S"
510(K) SUMMARY This summary of 510(k) safety and effectiveness infornation is being submitted in accordance with the requirements of 21 CFR 807.92. Submitter Information: SomnoMed Inc Date Summary Prepared:
More informationInspections, Compliance, Enforcement, and Criminal Investigations
Home > Inspections, Compliance, Enforcement, and Criminal Investigations > Enforcement Actions > Warning Letters Inspections, Compliance, Enforcement, and Criminal Investigations Ratzan, Judith M.D. 2/16/11
More informationCase: 1:18-cv Document #: 1 Filed: 07/26/18 Page 1 of 19 PageID #:1 IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF ILLINOIS
Case: 1:18-cv-05104 Document #: 1 Filed: 07/26/18 Page 1 of 19 PageID #:1 IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF ILLINOIS UNITED STATES OF AMERICA, ) ) Plaintiff, ) ) v. ) ) Civil
More informationRecall Guidelines. for Chinese Medicine Products
Recall Guidelines for Chinese Medicine Products April 2018 Recall Guidelines for Chinese Medicine Products Chinese Medicines Board Chinese Medicine Council of Hong Kong Compiled in September 2005 1 st
More informationEffective and Compliance Dates Applicable to Retailers, Manufacturers, Importers, and Distributors of Newly Deemed Tobacco Products
Effective and Compliance Dates Applicable to Retailers, Manufacturers, Importers, and Distributors of Newly Deemed Tobacco Quick Facts Retailers that mix and prepare e-liquids or create or modify vaporizers
More information4/26/2013. Libia Lugo Drug Specialist San Juan District Office Investigations Branch
Libia Lugo Drug Specialist San Juan District Office Investigations Branch The Food and Drug Administration (FDA) responsibilities extend to the 50 United States, the District of Columbia, Puerto Rico,
More informationInspections, Compliance, Enforcement, and Criminal Investigations
Home Inspections, Compliance, Enforcement, and Criminal Investigations Enforcement Actions Warning Letters Inspections, Compliance, Enforcement, and Criminal Investigations Burzynski Research Institute
More informationGENERAL INFORMATION AND INSTRUCTIONS
NON-PARTICIPATING MANUFACTURER CERTIFICATION FOR LISTING ON OREGON DIRECTORY GENERAL INFORMATION AND INSTRUCTIONS Who is required to file this Certification? Any tobacco product manufacturer who is a non-participating
More informationCALIFORNIA HOMEMADE FOOD ACT AB 1616 (GATTO) REGISTRATION / PERMITTING FORM. CFO Business Name:
LeslieLindbo,MBA,REHS DirectorofEnvironmentalHealth CALIFORNIA HOMEMADE FOOD ACT AB 1616 (GATTO) REGISTRATION / PERMITTING FORM CFO Business Name: CFO Physical Address: Owner Name: Mailing Address (if
More informationInspections, Compliance, Enforcement, and Criminal Investigations
Page 1 of 8 Home Inspections, Compliance, Enforcement, and Criminal Investigations Compliance Actions and Activities Warning Letters 2014 Inspections, Compliance, Enforcement, and Criminal Investigations
More informationWelcome to the Supply Network Market Quickstart Program
Welcome to the Supply Network Market Quickstart Program Exhibitor & Advertising Standards Unique & Free New Hope is the only media company in the natural products industry that has a dedicated Exhibitor
More informationInspections, Compliance, Enforcement, and Criminal Investigations. Central Texas Regional Blood & Tissue Center 07-Nov-03
1 of 7 6/10/2009 2:20 PM Inspections, Compliance, Enforcement, and Criminal Investigations Department of Health and Human Services Public Health Service Food and Drug Administration Dallas District 4040
More informationNOV Jo 6) ' 510(k) Summary
NOV 2 9 2004Jo 6) ' 510(k) Summary 1. Applicant Amest Corporation 303194 Espetranza Rancho Santa Margarita, CA 92688 Contact person: John Jest Amnest Corporation 30394 Espcranza Rancho Santa Margarita,
More informationInspections, Compliance, Enforcement, and Criminal Investigations
Home > Inspections, Compliance, Enforcement, and Criminal Investigations > Enforcement Actions > Warning Letters Inspections, Compliance, Enforcement, and Criminal Investigations Chawla, Sant P., M.D.
More informationFood Labeling: Revision of the Nutrition and Supplement Facts Labels and Serving Sizes of
This document is scheduled to be published in the Federal Register on 10/02/2017 and available online at https://federalregister.gov/d/2017-21019, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN
More informationNutritional Criteria for Labeling Claims
Nutritional Criteria for Labeling Claims Barbara O. Schneeman, Ph.D. Office of Nutrition, Labeling and Dietary Supplements Center for Food Safety and Applied Nutrition/ Food and Drug Administration Department
More informationLIVE INTERACTIVE YOUR DESKTOP. Food Recall Process. Cecilia M. Wolyniak Food and Drug Administration Office of Enforcement
LIVE INTERACTIVE LEARNING @ YOUR DESKTOP Food Recall Process Cecilia M. Wolyniak Food and Drug Administration Office of Enforcement Wednesday, December 9, 2009 LEGAL ISSUES Code of Federal Regulations
More informationU. AUG skeletal dynamics. 510(k) Summary of Safety and Effectiveness Skeletal Dynamics Geminus Volar Distal Radius Plate System
U. AUG 23 2011 00 skeletal dynamics 510(k) Summary of Safety and Effectiveness Skeletal Dynamics Geminus Volar Distal Radius Plate System Submitter: Skeletal Dynamics, LLC 6905 SW 67 Avenue Suite 201 Miami,
More information510(k) 21 Summary of Safety and Effectiveness
510(k) 21 Summary of Safety and Effectiveness This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirement of 21 CFR 807.92. Submitter's Identification:
More informationWARNING LETTER. ( (ORA05050) for OrapredCI (prednisolone sodium phosphate
+t-tlserviçès-,& v,ù',' : -::~.,'" ( -ldepartment OF HEALTH & HUMAN SERVICES 'P"~~\- Public Health Service Food and Drug Administration Rockville, MD 20857 TRANSMITTED BY FACSIMILE October 11, 2006 Jean-Jacques
More informationEnvironmental Health Department
COTTAGE FOOD OPERATIONS (CFO) REGISTRATION/PERMITTING FORM (CALIFORNIA HOMEMADE FOOD ACT AB 1616 (GATTO)) CFO Business Name: Owner Name: Date: CFO Physical Address: CFO City: CFO Zip: Website (If applicable):
More informationOverview of FDA Oversight and Enforcement on Drug Compounding
Overview of FDA Oversight and Enforcement on Drug Compounding Ruey Ju, Pharm.D., J.D. Senior Advisor for Compounding Compliance and Enforcement (Acting) Center for Drug Evaluation and Research Today s
More informationNutrition Labeling of Single- Ingredient Products and Ground or Chopped Meat and Poultry Products
Nutrition Labeling of Single- Ingredient Products and Ground or Chopped Meat and Poultry Products 1 Summary of Provisions in the Final Rule Major Cuts: The final rule requires nutrition labeling of the
More informationDietary Supplement Health and Education Act of 1994 Public Law rd Congress
Dietary Supplement Health and Education Act of 1994 Public Law 103-417 103rd Congress An Act To amend the Federal Food, Drug, and Cosmetic Act to establish standards with respect to dietary supplements,
More information'03 MAR 24 $1 :52
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administratin College Pa&, MD 20740 w lza@ 1 38 7 '03 MAR 24 $1 :52 Mr. Scott D. Kumpf General Counsel and Corporate Secretary
More informationFDA Laws & Pharmacy Practice
Objectives FDA Laws & Pharmacy Practice Tom Hazlet Pharmacy 543 October 6, 2004 Be able to discuss the evolution of food and drug law in the United States Be able to discuss the ways in which pharmacists
More informationGuidance for Industry DRAFT GUIDANCE. This guidance document is being distributed for comment purposes only.
Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act Guidance for Industry DRAFT GUIDANCE This guidance
More informationCassandra E. Curtis, M.D. 1/27/17
Cassandra E. Curtis, M.D. 1/27/17 CERTIFIED MAIL RETURN RECEIPT REQUESTED WARNING LETTER JAN 27, 2017 10903 New Hampshire Avenue Silver Spring, MD 20993 Cassandra E. Curtis, M.D. 45-01-02 4880 Century
More informationAgency Information Collection Activities; Submission for Office of Management and Budget
This document is scheduled to be published in the Federal Register on 01/28/2016 and available online at http://federalregister.gov/a/2016-01690, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN
More information7 Food and Drug Administration Via Federa 1 Express Center for Devices and Radiological Health 2098 Gaither Road Rockville, MD 20850
./ + I #~=% @fices.o # Jg DEPARTMENT OF HEACI H & HUMAN SERVICES - Public Health Service : %. % W(-I *4 +4~w.daa 7 Food and Drug Administration Via Federa 1 Express Center for Devices and JAN 25 2001 WARNING
More informationBorder Issues and Statistics: Regulatory Activities. Mr. Robert Deininger Southwest Import Director AFDO San Antonio, Texas
Border Issues and Statistics: Regulatory Activities Mr. Robert Deininger Southwest Import Director AFDO San Antonio, Texas U.S. Food & Drug Administration Mission Statement The Food & Drug Administration
More informationInspections, Compliance, Enforcement, and Criminal Investigations
Home > Inspections, Compliance, Enforcement, and Criminal Investigations > Enforcement Actions > Warning Letters Inspections, Compliance, Enforcement, and Criminal Investigations Punjwani, Sohail S., M.D.
More informationDetermination of Ginseng in Dietary Supplements and Dietary Ingredients. Stakeholder Panel on Dietary Supplements (SPDS)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 DRAFT AOAC SMPR 2016.XXX; Version 5; June 29, 2017. Method Name:
More informationJanuary 7, Dear Ms. Chung:
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center WO66-G609 Silver Spring, MD 20993-0002 January 7, 2015 Jeisys
More information(Tobacco Control Act), these products are tobacco products because they are made or derived from tobacco and intended for human consumption.
2015 > Knoxville Vapor LLC 4/2/15 (Tobacco Control Act), these products are tobacco products because they are made or derived from tobacco and intended for human consumption. Section 301(tt) Violation[1]
More informationNEURONETICS. 510(k) SUMMARY NEUROSTAR TMS THERAPY SYSTEM'
NEURONETICS 510(k) SUMMARY NEUROSTAR TMS THERAPY SYSTEM' 510(k) Owner: Neuronetics, Inc. DEC 1 6 Z008 1 Great Valley Parkway, Suite 2 Malvern, PA 19355 Phone: 610-640-4202 Fax: 610-640-4206 Company Contact:
More informationAs Introduced. 132nd General Assembly Regular Session H. B. No
132nd General Assembly Regular Session H. B. No. 560 2017-2018 Representative Lanese A B I L L To amend sections 923.41, 923.48, and 923.51 of the Revised Code to prohibit pet food from containing remains
More informationPlanning For The FDA s 'Deeming Rule' For E- Cigarettes
Law360, New York (September 21, 2015, 3:39 PM ET) -- The 2009 Family Smoking Prevention and Tobacco Control Act (TCA)[1] gave the U.S. Food and Drug Administration the authority to oversee the manufacture,
More informationSouthern California Section & Western Compendial Discussion Group
Association for Official and Analytical Chemists Southern California Section & Western Compendial Discussion Group October 6, 2011 Compliance Officer Bill Vitale, Food and Drug Administration Los Angeles
More informationInstrument, Surgical, Powered, Laser 79-GEX 21I CFR878-48
kor~f ¼ UL 2 62004 This 510(K) Summary of safety and effectiveness for the Millennium Dental Technologies PerioLase Dental Laser System is submitted in accordance with the requirements of the SMDA 1990
More informationPutting the Nutritional Supplement Industry to the Test: Looking for Transparency
Putting the Nutritional Supplement Industry to the Test: Looking for Transparency Frederick H. Fern @RickFern_HB ffern@harrisbeach.com Marina Plotkin @MarinaPlotkin_HB mplotkin@harrisbeach.com Putting
More information510(k) SUMMARY STATEMEMT. Mettler Traction Device, MTD 4000 OCT Mettler Electronics Corp South Claudina Street Anaheim, CA 92805
510(k) SUMMARY STATEMEMT OCT - 8 2009 Mettler Traction Device, MTD 4000 Submitter's Name: Address: Mettler Electronics Corp. 1333 South Claudina Street Anaheim, CA 92805 Telephone: 714-533-2221 x324 Fax:
More informationKo0 -t. Exhibit 2 MAY 3 0? 510 (K) Summay. Company Name: Columbia Scientific Development, LLC 420 NW I Ith Ave., Suite 617 Portland, Oregon 97209
Ko0 -t Exhibit 2 MAY 3 0? 510 (K) Summay Company Name: Columbia Scientific Development, LLC 420 NW I Ith Ave., Suite 617 Portland, Oregon 97209 Contact: Stephen Shulman Phone: 734-663-0132 Fax: 734-663-1306
More informationAFDO Conference June 9, Mercedes Mota, Director Medical Device, Surgical Care Johnson & Johnson Quality & Compliance Worldwide
AFDO Conference June 9, 2009 Mercedes Mota, Director Medical Device, Surgical Care Johnson & Johnson Quality & Compliance Worldwide Government Agencies 483 observations A violation of the FD&C Act involving
More informationNDA NDA APPROVAL
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Silver Spring MD 20993 NDA 022200 NDA APPROVAL Amylin Pharmaceuticals, Inc. Orville Kolterman, M.D. Sr. Vice President, Research & Development
More information